NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Gamida Cell Ltd (NASDAQ: GMDA)
GMDA Technical Analysis
5
As on 26th Apr 2024 GMDA STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.46 & Strong Sell for SHORT-TERM with Stoploss of 1.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GMDASTOCK Price
Open | 0.02 | Change | Price | % |
High | 0.02 | 1 Day | 0.00 | 0.00 |
Low | 0.02 | 1 Week | 0.00 | 0.00 |
Close | 0.02 | 1 Month | -0.30 | -93.75 |
Volume | 595822 | 1 Year | -1.73 | -98.86 |
52 Week High 2.31 | 52 Week Low 0.01 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
GNLN | 0.01 | -50.00% |
AGMH | 0.05 | 25.00% |
OMEX | 1.51 | 77.65% |
NVDA | 111.01 | 4.30% |
WW | 0.40 | 166.67% |
TSLA | 284.95 | 9.80% |
INTC | 20.05 | -6.70% |
OPEN | 0.76 | -2.56% |
LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
GMDA Daily Charts |
GMDA Intraday Charts |
Whats New @ Bazaartrend |
GMDA Free Analysis |
|
GMDA Important Levels Intraday
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
GMDA Forecast April 2025
4th UP Forecast | 1.06 |
3rd UP Forecast | 0.73 |
2nd UP Forecast | 0.52 |
1st UP Forecast | 0.31 |
1st DOWN Forecast | -0.27 |
2nd DOWN Forecast | -0.48 |
3rd DOWN Forecast | -0.69 |
4th DOWN Forecast | -1.02 |
GMDA Weekly Forecast
4th UP Forecast | 1.33 |
3rd UP Forecast | 0.91 |
2nd UP Forecast | 0.65 |
1st UP Forecast | 0.39 |
1st DOWN Forecast | -0.35 |
2nd DOWN Forecast | -0.61 |
3rd DOWN Forecast | -0.87 |
4th DOWN Forecast | -1.29 |
GMDA Forecast2025
4th UP Forecast | 4.84 |
3rd UP Forecast | 3.29 |
2nd UP Forecast | 2.34 |
1st UP Forecast | 1.38 |
1st DOWN Forecast | -1.34 |
2nd DOWN Forecast | -2.3 |
3rd DOWN Forecast | -3.25 |
4th DOWN Forecast | -4.8 |
Gamida Cell Ltd ( NASDAQ USA Symbol : GMDA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GMDA Other Details
Segment | EQ | |
Market Capital | 230672336.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
GMDA Address
![]() |
GMDA Latest News
GMDA Business Profile
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel. Address: 5 Nahum Heftsadie Street, Jerusalem, Israel, 91340
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service